Overview

IM and IV SPL026 Drug Product in Healthy Participants

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test SPL026 given via injection into a muscle in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Small Pharma Ltd